drugset / Trial / NCT00246376

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

NCT00246376

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the efficacy of diet and exercise (DE), with and without niacin and fenofibrate, in reducing the cardiovascular risk of patients with HIV lipodystrophy or dyslipidemia.

Timeline

Start
2004-01
Primary completion
2009-09
Completion
2012-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 120 mg
Subject Niacin Small molecule 2 g